Review Article
Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy
Table 1
Drugs targeting specific CSCs and their modes of action.
| Compounds | Mechanism of action | Type of CSCs | References |
| Temozolomide (TMZ) | Reversal of EMT and chemosensitizing CSCs | Glioblastoma | [27] | STA-4783 | Targets OS by Hsp70 induction and induces ROS within CCs | Breast | [28] | Geldanamycin | Inhibition of the TRAP1 chaperone function | Breast, lung, and neural | [31] | Rottlerin (ROT) | Inhibitor of PI3K/Akt/mTOR pathway and inducer of apoptosis | Pancreatic | [33] | Bardoxolone methyl | Nrf2 inhibitor | Leukemia | [34] | Resveratrol | Wnt inhibitor | Breast | [35] | Honokiol | Notch inhibitor | Melanoma | [36] | Chloroquine (CQ) | Autophagy inducer | Colorectal | [37] | Pemetrexed | Folate antagonist | Lung | [38] | Melatonin | Induces autophagy by increasing ROS | Glioma | [39] | Salinomycin | K+-ionophore and triggers autophagy | General CSCs | [40] | BMD188 | Proapoptotic | Prostate cancer | [41] | Gossypol | Hsp70 induction, ROS induction | Breast, leukemia | [42] | PUFAs | Induces apoptosis and autophagy | Colorectal | [43] | TrxR | ROS scavenger | Cervical | [44] |
|
|